Is simultaneous splenectomy an additive risk factor in surgical treatment for active endocarditis?
Simultaneous valve surgery and splenectomy is an approach for active endocarditis complicated by splenic lesions with a low 180-day mortality. Despite the expected risk elevation by septic lesions and the additive trauma of a laparotomy, patients with simultaneous splenectomy had a favourable outcome regarding early mortality and mortality at 6 months.
The prevalence of MAU in hypertensive patients is higher in smokers than in non-smokers with a strong dose dependency.